What Are the Clinical Applications of Bispecific Monoclonal Antibodies?
BsAbs have shown promise in the treatment of various cancers, including hematological malignancies and solid tumors. Some of the clinical applications include:
Hematological Cancers: BsAbs like Blinatumomab (Blincyto) have been approved for the treatment of acute lymphoblastic leukemia (ALL). Solid Tumors: Research is ongoing to evaluate the efficacy of bsAbs in treating solid tumors such as breast cancer, lung cancer, and colorectal cancer. Combination Therapies: BsAbs are being studied in combination with other treatments such as chemotherapy, radiation, and other immunotherapies to enhance their effectiveness.
